Literature DB >> 28294514

Intermittent vemurafenib therapy in malignant melanoma.

Nicolai Treiber1, Margit Anna Huber1, Lars Alexander Schneider1, Karin Scharffetter-Kochanek1, Erwin Schultz2, Dirk Debus2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28294514     DOI: 10.1111/ddg.13034

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  1 in total

1.  Taking advantage of drug resistance, a new approach in the war on cancer.

Authors:  Liqin Wang; Rene Bernards
Journal:  Front Med       Date:  2018-07-18       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.